Clinical evaluation of an over-the-counter hearing aid (TEO First®) in elderly patients suffering of mild to moderate hearing loss. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Sacco, Guillaume; Gonfrier, Sébastien; Teboul, Bernard; Gahide, Ivan; Prate, Fredéric; Demory-Zory, Mathilde; Turpin, Jean-Michel; Vuagnoux, Claire; Genovese, Philippe; Schneider, Stéphane; Guérin, Olivier; Guevara, Nicolas
• Is Part Of: BMC geriatrics. Volume 16:Issue 1(2016)
• Page Start: 1
• Page End: 7
• Publication Date: 2016-12
• Subjects: OTC Hearing aid -- Elderly -- Hearing rehabilitation; Geriatrics -- Periodicals; 618.97005
• DOI: 10.1186/s12877-016-0304-4
• Languages: English
• ISSNs: 1471-2318

Abstract

Abstract Background Presbycusis has a direct influence on autonomy of the elderly but hearing aids lack of affordability. Moreover a recent review demonstrate that electroacoustic characteristics of OTC hearing aids were generally not suitable for the elderly people. In our study, we assessed the clinical value of a new over-the-counter (OTC) hearing aid device (TEO First®) in the elderly. Method This prospective monocentric open label study included patients over 60 years of age with a mild to moderate presbycusis. Patients were assessed with acceptable noise level test (ANL), pure tone (PTA) and speech (SA) audiometry in silent and noisy environment, with and without TEO First®. A Glasgow Hearing Aid Benefit Profile, acceptability and satisfaction surveys were completed after one month of using the device. Results Thirty one patients were included. There was an improvement of hearing with TEO First® in silence (SA: +39.2 %, p < 0.01; PTA: -9.04 dB, p < 0.01) or in noise (SA +47.7 %, p < 0.01; PTA: -5.23 dB, p < 0.05). After one month of use of the device, quality of life has improved with regards to the following parameters: decrease of perceived hearing difficulties during conversation without background noise (-9.6 %p = 0.018), in conversation with several people (-16.2 %p = 0.0076), decrease of negative emotions while watching TV (-18.5 %p = 0.011), during conversation without background noise (-16.5 %p = 0.0024), during conversation in noisy background (-17.1 %p = 0.027) and during conversation with several people (-20 %p = 0.014). The acceptability of the device was low to moderate. Conclusion TEO First® is an effective OTC hearing aid that improves the patient's quality of life. Trial registration Current Controlled TrialsNCT01815788